Industry: Pharmaceuticals, Biotechnology
Alfacell Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer and other diseases, using its ribonuclease (RNase) technology platform. ONCONASE(R) (ranpirnase), Alfacell’s lead investigational drug candidate, is currently being evaluated in several studies, including a Phase IIIb registration study for unresectable malignant mesothelioma (MM). A Phase I / II trial evaluating ONCONASE in Non-Small Cell Lung Cancer (NSCLC) is also in progress. ( www.alfacell.com )
Alfacell Corporation
225 Belleville Ave
Bloomfield, New Jersey 07003
USA
Tel: (973) 748-8082
Fax: (973) 748-1355